IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Alkem Laboratories Limited is an Pharmaceutical based company, located in Mumbai, Alkem Laboratories Limited IPO size was 1349.61 Cr. and was issued at 1050.00 per share. The share of Alkem Laboratories Limited were listed at 1381.45 per share and are currently trading at 4953.30 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Alkem Laboratories operates in Pharmaceutical and Development Manufacture And Sale Of Pharmaceutical And Neutraceutical Products. The Issue is listed on BSE,NSE in Dec, 2015. Alkem Laboratories IPO size was 1349.61 Cr. with Issue price of 1050.00 .
Merchant Banker(s) of Alkem Laboratories IPO: Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited
Alkem Laboratories IPO subscription was 44.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Alkem Laboratories IPO listed at a listing price of 1381.45 against the offer price of 1050.00.
The current market price of Alkem Laboratories is 4953.30.
Why Us?
